Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MicrobioTac: Immunosuppressants and Microbiome in Kidney Transplant
NCT04207177Phase 4Active, not recruiting
- Sponsor
- Oslo University Hospital
- Start
- Oct 2019
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate mofetil, tacrolimus + Wuzhi capsule in kidney transplant rejection, sponsored by Oslo University Hospital. Started Oct 2019; status: active, not recruiting.
02
Drugs
mycophenolate mofetiltacrolimus + Wuzhi capsule
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT04207177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04207177.